Lv1
30 积分 2024-02-07 加入
The road to implementation of pharmacokinetic-guided dosing of factor replacement therapy in hemophilia and allied bleeding disorders. Identifying knowledge gaps by mapping barriers and facilitators
20天前
已完结
A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates
24天前
已完结
Inter-individual variability in pharmacokinetics and clinical features in pediatric patients with severe hemophilia A
24天前
已完结
The road to implementation of pharmacokinetic-guided dosing of factor replacement therapy in hemophilia and allied bleeding disorders. Identifying knowledge gaps by mapping barriers and facilitators
24天前
已完结
Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH
1个月前
已完结
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH
1个月前
已完结
Influence of blood group and von Willebrand factor on population pharmacokinetics and dose individualization of recombinant factor VIII in Taiwanese patients with haemophilia A
1个月前
已完结
Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities-a practical review
1个月前
已完结
Modulation of factor VIII pharmacokinetics by genetic components in factor VIII receptors
1个月前
已完结
皖公网安备34019202002308
